Penserra Capital Management LLC Harmony Biosciences Holdings, Inc. Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$33.54 - $52.15 $1.36 Million - $2.11 Million
40,434 Added 110.0%
77,192 $3.76 Million
Q1 2022

May 13, 2022
BUY
$33.14 - $51.13 $307,174 - $473,923
9,269 Added 33.72%
36,758 $1.79 Million
Q4 2021

Feb 15, 2022
BUY
$34.09 - $43.91 $937,100 - $1.21 Million
27,489 New
27,489 $1.17 Million

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.2M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.94B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email